Tofacitinib API
Lewens Labs develops and manufactures Tofacitinib API — Janus kinase (JAK) inhibitor, an oral JAK inhibitor for immune-mediated inflammatory disease — used in rheumatoid arthritis and immune-mediated inflammatory disease, at its GMP facility in Gujarat, India.
Note for Lewens: populate CAS, formula, grade, DMF/CEP & registrations for Tofacitinib from the Regulatory master list.
Why Tofacitinib rewards process depth.
Tofacitinib involves chiral pyrrolopyrimidine synthesis with strict stereochemical and genotoxic-impurity control.
Lewens' integrated platform — process R&D, analytical development and manufacturing under one team — is built for exactly this kind of technically demanding molecule. We can support Tofacitinib as commercial supply, as a second source, or as a development and custom-synthesis programme through our CDMO platform.
Three ways to source Tofacitinib.
Ongoing supply
Reliable, on-specification commercial quantities of Tofacitinib API for your registered product.
Alternate supplier
De-risk your supply chain for Tofacitinib with a dependable additional or backup source.
Custom & CDMO
Process development, improvement or exclusive arrangements for Tofacitinib under NDA.
More in Immunology.
See the full portfolio for related molecules.
All products →Tofacitinib API — FAQs.
Does Lewens manufacture Tofacitinib API?
Can Lewens supply Tofacitinib as a second source?
What is Tofacitinib used for?
Need Tofacitinib API?
Request specifications, samples or DMF/CEP documentation — or discuss a second-source or custom-synthesis programme.